Gastrointestinal symptoms are the most common side effect of GLP-1 medications
Future work will optimize non-invasive platforms (e.g., exosome-engineered carriers), as ICV remains a preclinical tool for mechanistic studies
So, proinflammatory and procoagulant proteins, including HMGB1, TNF?, ICAM1 and NFkB, disrupt the BBB and tight junction proteins, including ZO-1, occludin and claudin-5, are critical for the formation and maintenance of BBB integrity
Methionine: As a crucial player in fat breakdown, especially in the liver, methionine facilitates effective fat metabolism, helping you reach your weight loss goals
Hypoglycemic Agents: Sulfonylureas and Insulin : Combining GLP-1 receptor agonists with sulfonylureas or insulin can increase the risk of hypoglycemia (low blood sugar)
Nutritional support A balanced, nutrient-dense diet can enhance the weight loss effects of GLP-1 agonists while providing essential nutrients for overall health